Live NSE:RUBICON share price ₹1,778.30 (+1.21%), market cap ₹294B, P/E 101.7 · Healthcare sector. MarketRipple covers the investment thesis, ripple-chain impact and sector outlook for RUBICON.
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant.
Open
₹1,766.70
High
₹1,834.90
Low
₹1,766.70
Prev. Close
₹1,757.00
52W High
₹1,899.00
52W Low
₹570.75
Day range
₹1,766.70–₹1,834.90
52-week range
₹570.75–₹1,899.00
Volume
181K
P/E
101.7
ROE
0.0%
D/E
24.1
Margin
14.9%
Rubicon Research Limited (NSE: RUBICON) is currently trading at ₹1,778.30 (+1.21%).
Rubicon Research Limited's market capitalization is ₹294B.
Rubicon Research Limited's price-to-earnings (P/E) ratio is 101.7.
Rubicon Research Limited operates in the Healthcare sector (Drug Manufacturers - General).
Analyst consensus on Rubicon Research Limited currently reads neutral, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.